Neurofibroma historical perspective: Difference between revisions

	Neurofibroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Neurofibroma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Neurofibroma historical perspective On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Neurofibroma historical perspective All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Neurofibroma historical perspective
CDC on Neurofibroma historical perspective
Neurofibroma historical perspective in the news
Blogs on Neurofibroma historical perspective
Directions to Hospitals Treating Neurofibroma
Risk calculators and risk factors for Neurofibroma historical perspective

Revision as of 13:32, 28 March 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Neurofibroma may be classified into following 5 subtypes

@@ Line 3: / Line 3: @@
 {{CMG}}; {{AE}}{{S.M.}}
 ==Overview==
-[[Neurofibroma]] may be [[Classification|classified]] into 5 subtypes: [[cutaneous]]/[[dermal]]/[[Localized disease|localized]], [[subcutaneous]], [[diffuse]], [[intramuscular]], and [[plexiform neurofibroma]]. [[Plexiform neurofibroma|Plexiform neurofibromas]] may be further [[Subclass (biology)|sub-classified]] into [[diffuse]] and [[nodular]] [[Plexiform neurofibroma|plexiform]].
 ==Classification==